Form 8-K - Current report:
SEC Accession No. 0001396814-21-000048
Filing Date
2021-08-03
Accepted
2021-08-03 08:02:29
Documents
14
Period of Report
2021-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20210803.htm   iXBRL 8-K 34104
2 EX-99.1 pcrx-6302021x991.htm EX-99.1 246858
6 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01a.jpg GRAPHIC 27796
  Complete submission text file 0001396814-21-000048.txt   477396

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20210803.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20210803_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20210803_pre.xml EX-101.PRE 12516
7 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20210803_htm.xml XML 11935
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 211138041
SIC: 2834 Pharmaceutical Preparations